Literature DB >> 3197764

Keratoconus: I. Biochemical studies.

J W Critchfield1, A J Calandra, A B Nesburn, M C Kenney.   

Abstract

The present study analyses collagenous and non-collagenous components from age-matched normal and keratoconus corneas. Intact keratoconus corneas showed decreased collagen, total protein, and hydroxylysine levels, with normal reducible collagen cross-linking. Non-collagenous fractions were isolated from corneas with a 4 M guanidine procedure. As demonstrated by PAGE-silver stain, the keratoconus cornea guanidine extracts had a 75 kDa band that was absent in normal cornea guanidine extracts. In addition, there was a markedly increased level of protein, uronic acid and neutral hexose in keratoconus extracts as compared with controls. Our Western blot studies showed increased affinity for the castor-bean agglutinin (RCA120, specific for terminal galactose) in the keratoconus extracts as compared with normals. These data suggest the presence of an abnormal noncollagenous component in keratoconus corneas.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3197764     DOI: 10.1016/s0014-4835(88)80047-2

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  14 in total

1.  Correlation between the COL4A3, MMP-9, and TIMP-1 polymorphisms and risk of keratoconus.

Authors:  Ramin Saravani; Davood Yari; Samira Saravani; Farzaneh Hasanian-Langroudi
Journal:  Jpn J Ophthalmol       Date:  2017-02-14       Impact factor: 2.447

2.  Polymorphisms in COL4A3 and COL4A4 genes associated with keratoconus.

Authors:  Mirna Stabuc-Silih; Metka Ravnik-Glavac; Damjan Glavac; Marko Hawlina; Mojca Strazisar
Journal:  Mol Vis       Date:  2009-12-20       Impact factor: 2.367

3.  Resistance of corneal RFUVA–cross-linked collagens and small leucine-rich proteoglycans to degradation by matrix metalloproteinases.

Authors:  Yuntao Zhang; Xiuli Mao; Tyler Schwend; Stacy Littlechild; Gary W Conrad
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-02-05       Impact factor: 4.799

4.  Biochemical studies on human corneal proteoglycans--a comparison of normal and keratoconic eyes.

Authors:  J Wollensak; E Buddecke
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

Review 5.  The pathogenesis of keratoconus.

Authors:  A E Davidson; S Hayes; A J Hardcastle; S J Tuft
Journal:  Eye (Lond)       Date:  2013-12-20       Impact factor: 3.775

6.  An Evaluation of Lysyl Oxidase-Derived Cross-Linking in Keratoconus by Liquid Chromatography/Mass Spectrometry.

Authors:  Anna Takaoka; Natasha Babar; Julia Hogan; MiJung Kim; Marianne O Price; Francis W Price; Stephen L Trokel; David C Paik
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-01-01       Impact factor: 4.799

7.  Pathophysiology of Keratoconus: What Do We Know Today.

Authors:  Uri Soiberman; James W Foster; Albert S Jun; Shukti Chakravarti
Journal:  Open Ophthalmol J       Date:  2017-07-31

8.  The keratoconus corneal proteome: loss of epithelial integrity and stromal degeneration.

Authors:  Raghothama Chaerkady; Hanjuan Shao; Sherri-Gae Scott; Akhilesh Pandey; Albert S Jun; Shukti Chakravarti
Journal:  J Proteomics       Date:  2013-05-29       Impact factor: 4.044

9.  Enrichment of pathogenic alleles in the brittle cornea gene, ZNF469, in keratoconus.

Authors:  Judith Lechner; Louise F Porter; Aine Rice; Veronique Vitart; David J Armstrong; Daniel F Schorderet; Francis L Munier; Alan F Wright; Chris F Inglehearn; Graeme C Black; David A Simpson; Forbes Manson; Colin E Willoughby
Journal:  Hum Mol Genet       Date:  2014-06-03       Impact factor: 6.150

Review 10.  Pathogenesis of Keratoconus: The intriguing therapeutic potential of Prolactin-inducible protein.

Authors:  Rabab Sharif; Sashia Bak-Nielsen; Jesper Hjortdal; Dimitrios Karamichos
Journal:  Prog Retin Eye Res       Date:  2018-07-13       Impact factor: 19.704

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.